ACR Meeting Abstracts
Abstract Number: 1888 • ACR/ARP Annual Meeting 2019
Emma de Moel1, Jürgen Rech 2, Michael Mahler 3, Johannes Roth 4, Anne Schouffoer 5, Karel Ronday 6, Thomas Huizinga 5, CF Allaart 7, René Toes 5, Georg Schett 8 and Diane van der Woude 1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany, 3Inova Diagnostics, San Diego, CA, 4University of Muenster, Muenster, Germany, 5Leiden University Medical Center, Leiden, Netherlands, 6Haga Ziekenhuis, The Hague, Netherlands, 7Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 8Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany
Background/Purpose: The ability to accurately predict whether RA patients will flare following DMARD-tapering would open doors in clinical decision-making for achieving drug-free remission (DFR). Calprotectin…